I keep seeing questions about frozen semaglutide and frozen tirzepatide, usually after someone makes a mistake like leaving it in the car...

You may have seen the headlines about Eli Lilly’s orforglipron outperforming Novo Nordisk’s oral semaglutide. On the surface, it sounds...

In a major shake-up that’s bound to impact millions of patients, CVS Caremark is cutting ties with Eli Lilly’s weight loss drug Zepbound—and making Novo Nordisk’s Wegovy the go-to GLP-1 for obesity treatment. If your insurance runs through CVS Caremark, here’s what’s changing, why it’s happening, and what you should do next.

The landscape of diabetes and obesity management is on the cusp of a significant transformation, driven by the development of oral...

The window for GLP-1 compounders to tap dance around the compounding ban is almost closed — and anyone still trying to squeeze through could end up with some bruised fingers. A federal court ruling has backed the FDA’s determination that shortages of Wegovy and Ozempic are officially over, setting up a sharp end to the era of legally available compounded GLP-1s.

The battle over compounded versions of blockbuster weight-loss drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro,...

As demand for GLP-1 medications like Ozempic (semaglutide) continues to surge in the U.S., the Food and Drug Administration (FDA) and...

If you’ve heard someone mention Ozempic or Wegovy recently, you’ve already heard of semaglutide—just not by its chemical name. Semaglutide is a medication that has changed the game in two major areas: managing type 2 diabetes and helping people lose weight.